Telehealth giant Hims will soon sell its own version of Ozempic that costs just a quarter of the price of the name brand.<\/p>\n
Hims, a wellness start-up known for its hair and sex supplements, announced Monday that it will sell a ‘copycat’ of semaglutide, the active ingredient in Ozempic and Wegovy.\u00a0\u00a0<\/p>\n
This is known as compounding, which is when companies can offer prescription drugs without FDA approval to combat shortages.\u00a0<\/p>\n
The injection cost will start as just $199 for a month’s supply, whereas Ozempic and Wegovy can total over $1,300. This price also includes unlimited consultations with a doctor.\u00a0<\/p>\n
Hims did not announce when the drug will be available.\u00a0<\/b><\/u><\/p>\n
Supplement giant Hims will sell its own version of semaglutide, the active ingredient in Ozempic and Wegovy, \uc13c\ud2b8\ub9bd\uad6c\ub9e4<\/a> for just $199 per month<\/p>\n Hims also specializes in sexual health, hair loss, and mental health supplements and \uc5e0\ube45\uc2a4\uc5d0\uc2a4 \uc0ac\uc6a9\ubc95<\/a> medications<\/b><\/p>\n Hims said the goal is to help customers get access to the drugs without ‘navigating the shortages and costs that are currently limiting access to the branded medications.’\u00a0<\/p>\n The news comes as several types of drugs, including Ozempic and Wegovy face record-high shortages.\u00a0<\/p>\n